Douglas M. Brown
Keine laufenden Positionen mehr
Profil
Douglas M.
Brown worked as a Senior Managing Director at Leerink Partners LLC from 2015 to 2020 and as the Chief Strategy & Corporate Development Officer at NeoGenomics, Inc. from 2020 to 2022.
He received an undergraduate degree from The University of Texas at Austin and an MBA from The Fuqua School of Business.
Ehemalige bekannte Positionen von Douglas M. Brown
| Unternehmen | Position | Ende |
|---|---|---|
| NEOGENOMICS, INC. | Corporate Officer/Principal | 27.05.2022 |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Corporate Officer/Principal | 01.01.2020 |
Ausbildung von Douglas M. Brown
| The University of Texas at Austin | Undergraduate Degree |
| The Fuqua School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEOGENOMICS, INC. | Health Services |
| Private Unternehmen | 1 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
